Los Angeles Capital Management
SCMP

Los Angeles Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Los Angeles Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-14,018
Closed -$252K – 1468
2017
Q4 		$252K Sell
14,018
-3,535
-20% -$43.5K ﹤0.01% 1214
2017
Q3 		$207K Buy
+17,553
New +$197K ﹤0.01% 1246

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Los Angeles Capital Management's SCMP Position: Q1 2018 in Review

Los Angeles Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 14,018 shares — an estimated $252K sold.

Los Angeles Capital Management first reported a position in SCMP in Q3 2017 and held it in 2 quarters. The position peaked at $252K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Los Angeles Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Los Angeles Capital Management sold 14,018 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $252K.
  • Los Angeles Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Los Angeles Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $252K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Los Angeles Capital Management's 13F filing for Q1 2018, filed 27 Apr 2018.